Medstart ApS: Financial statements 2023
CVR: 42857319
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Medstart ApS (CVR 42857319) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,101,191 and a net result of DKK 695. Equity in the 2023 report amounted to DKK 145,461. The solvency ratio was 44.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,101,191
- Profit/Loss
- DKK 695
- Equity
- DKK 145,461
- Total Assets
- DKK 325,128
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Medstart ApS has published its interim report for the period November 25, 2021 – December 31, 2022.
About Medstart ApS
Medstart ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2021. The company is registered under the industry Alment praktiserende lægers aktiviteter. The management consists of Fredrik Bertil Meurling. The board consists of Fredrik Bertil Meurling (chair) and Eva Karin Maria Flaig. The company is owned by Yazen Health AB. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,436,998 and a net result of DKK 2,949 compared with DKK -263,017 the year before. Equity in the 2025 report amounted to DKK -114,607.